Kinvard Bio is creating a new class of antibiotics to treat drug-resistant infections and diseases.

Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.

GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas. 

Harvard researchers have pioneered a groundbreaking method for generating large numbers of adult skeletal-muscle satellite cells, also known as muscle stem cells, in vitro.